Is Carfilzomib a chemotherapy drug or a targeted drug?

Carfilzomib (Carfilzomib) is a targeted drug commonly used to treat multiple myeloma (Multiple Myeloma). Multiple myeloma is a malignant tumor in the leukemia and lymphoma system characterized by abnormal proliferation of plasma cells in the bone marrow. Carfilzomib's primary mechanism of action involves inhibiting the function of the proteasome, one of the primary mechanisms of intracellular protein degradation. This mechanism plays an important role in the pathological process of multiple myeloma.

Unlike traditional chemotherapy drugs, carfilzomib does not destroy rapidly dividing cells in a non-specific manner, but kills cancer cells by specifically interfering with the protein degradation process inside tumor cells. This targeted effect makes it more effective in inhibiting the growth and spread of tumors while reducing damage to healthy cells, thus mitigating adverse side effects during treatment.

Carfilzomib is usually given to patients in the form of an injection, so the dose of the drug can be precisely adjusted to ensure optimal therapeutic effects. Although it is widely used in the treatment of multiple myeloma, patients should receive treatment under the supervision of a doctor to ensure safety and effectiveness, because targeted drugs may also be accompanied by some specific adverse reactions. Overall, carfilzomib represents an innovative approach in modern cancer treatment and is expected to improve the survival and quality of life of patients with multiple myeloma by precisely intervening in tumor growth mechanisms.

Carfilzomib has been launched in China and is included in medical insurance. Patients can buy it domestically at a price of around 8,000 to 9,000 yuan. Please consult the local hospital pharmacy for specific prices. In foreign countries, the original drug of carfilzomib is mainly available, and the cheaper version is the European version of the original drug, which costs around 5,000. And the medicinal ingredients and efficacy are the same as those of domestic original medicines.